Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

69.0200 EUR 0.0300 0.04%

As of 11:35:00 ET on 04/24/2015.

Company Profile for UCB SA (UCB)

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Contact Information

UCB SA

Allee de la Recherche 60
Brussels, 1070
Belgium
Phone: 32-2-559-99-99
Fax: 32-2-559-99-00

Key Executives for UCB SA (UCB)

Jean-Christophe TellierChief Executive OfficerBharat TewarieChief Marketing Officer
Detlef ThielgenExec VP/CFOMark D McDadeExec VP/COO
Fabrice EnderlinExec VP/Chief Talent OfficerIsmail KolaExec VP/Pres:Newmedicines
Anna S RichoExec VP/General CounselEmmanuel CaeymaexExec VP/Immunology:Patient
Jeff WrenExec VP/Neurology:PatientIris Loew-FriedrichExec VP:Biopharma Dev Solutions
France NivelleVP:Global CommunicationDirk TeuwenVP:Societal Responsibility
Antje WitteVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil